Therapeutic Advances in Chronic Disease

2.9(top 20%)

impact factor

599(top 50%)

papers

10.8K(top 20%)

citations

51(top 10%)

h-index

3.0(top 20%)

impact factor

685

all documents

12.0K

doc citations

79(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease	Therapeutic Advances in Chronic Disease	2016	230
2	Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians	Therapeutic Advances in Chronic Disease	2012	201
3	Obstructive sleep apnoea syndrome and its management	Therapeutic Advances in Chronic Disease	2015	193
4	Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses	Therapeutic Advances in Chronic Disease	2016	177
5	Epidemiology of sarcoidosis: current findings and future directions	Therapeutic Advances in Chronic Disease	2018	175
6	Early onset type 2 diabetes: risk factors, clinical impact and management	Therapeutic Advances in Chronic Disease	2014	172
7	Radiation-induced small bowel disease: latest developments and clinical guidance	Therapeutic Advances in Chronic Disease	2014	171
8	Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review	Therapeutic Advances in Chronic Disease	2015	169
9	Treatment of painful diabetic neuropathy	Therapeutic Advances in Chronic Disease	2015	158
10	Cognitive dysfunction with aging and the role of inflammation	Therapeutic Advances in Chronic Disease	2011	154
11	Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance	Therapeutic Advances in Chronic Disease	2013	141
12	Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis	Therapeutic Advances in Chronic Disease	2020	133
13	Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials	Therapeutic Advances in Chronic Disease	2011	121
14	Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis	Therapeutic Advances in Chronic Disease	2018	121
15	Neurological manifestations of long-COVID syndrome: a narrative review	Therapeutic Advances in Chronic Disease	2022	120
16	The diagnosis and treatment of chronic migraine	Therapeutic Advances in Chronic Disease	2015	119
17	Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications	Therapeutic Advances in Chronic Disease	2014	117
18	Strategies for dementia prevention: latest evidence and implications	Therapeutic Advances in Chronic Disease	2017	112
19	Emerging treatments for inflammatory bowel disease	Therapeutic Advances in Chronic Disease	2020	110
20	Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy	Therapeutic Advances in Chronic Disease	2016	108
21	The emerging role of epigenetics in cardiovascular disease	Therapeutic Advances in Chronic Disease	2014	107
22	The future role of gut hormones in the treatment of obesity	Therapeutic Advances in Chronic Disease	2014	106
23	Update on the therapy of Behçet disease	Therapeutic Advances in Chronic Disease	2014	104
24	The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review	Therapeutic Advances in Chronic Disease	2018	103
25	Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction	Therapeutic Advances in Chronic Disease	2019	98
26	Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment	Therapeutic Advances in Chronic Disease	2018	90
27	Platelet-rich plasma in osteoarthritis treatment: review of current evidence	Therapeutic Advances in Chronic Disease	2019	88
28	HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis	Therapeutic Advances in Chronic Disease	2019	86
29	Bisphosphonates for the treatment of osteoporosis: insights for clinicians	Therapeutic Advances in Chronic Disease	2010	84
30	Infliximab in inflammatory bowel disease	Therapeutic Advances in Chronic Disease	2019	82
31	Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases	Therapeutic Advances in Chronic Disease	2016	81
32	N⁶-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury	Therapeutic Advances in Chronic Disease	2020	80
33	Opioid-induced constipation: advances and clinical guidance	Therapeutic Advances in Chronic Disease	2016	79
34	Pharmacotherapy for obesity: novel agents and paradigms	Therapeutic Advances in Chronic Disease	2014	78
35	Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases	Therapeutic Advances in Chronic Disease	2014	76
36	Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?	Therapeutic Advances in Chronic Disease	2015	76
37	Prevention of infection caused by immunosuppressive drugs in gastroenterology	Therapeutic Advances in Chronic Disease	2013	72
38	New findings in osteoarthritis pathogenesis: therapeutic implications	Therapeutic Advances in Chronic Disease	2013	71
39	Optimal treatment of laryngopharyngeal reflux disease	Therapeutic Advances in Chronic Disease	2013	70
40	Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life	Therapeutic Advances in Chronic Disease	2019	68
41	Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications	Therapeutic Advances in Chronic Disease	2015	67
42	Latest evidence on gout management: what the clinician needs to know	Therapeutic Advances in Chronic Disease	2012	65
43	Pegylated interferon and ribavirin treatment for hepatitis C virus infection	Therapeutic Advances in Chronic Disease	2011	63
44	Dietary compounds as potential modulators of microRNA expression in psoriasis	Therapeutic Advances in Chronic Disease	2019	63
45	Prospects for treating osteoarthritis: enzyme–protein interactions regulating matrix metalloproteinase activity	Therapeutic Advances in Chronic Disease	2012	62
46	Glaucoma management: relative value and place in therapy of available drug treatments	Therapeutic Advances in Chronic Disease	2014	62
47	Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management	Therapeutic Advances in Chronic Disease	2016	59
48	Montelukast in asthma: a review of its efficacy and place in therapy	Therapeutic Advances in Chronic Disease	2011	57
49	Exercise training in chronic heart failure	Therapeutic Advances in Chronic Disease	2013	55
50	Management of cirrhotic ascites	Therapeutic Advances in Chronic Disease	2015	55

Scientometrics

Overviews

Citing Bodies

Therapeutic Advances in Chronic Disease

Top Articles